However, G-MDSCs accumulate and restrict immune responses in a variety of diseases, such as multiple myeloma [34], late sepsis [3], COVID-19 [4], malaria infection [19], and non-small cell lung cancer with LKB1-inactivating mutations [21]. This evidence concerns the gene STK11 and COVID-19.